Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021
Zymergen, a leader in biofacturing, will release its financial results for Q1 2021 on May 24, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zymergen, a leader in biofacturing, will release its financial results for Q1 2021 on May 24, 2021. Management will discuss the results along with business developments and outlook during a conference call at 1:30 PM PT. The call can be accessed via a webcast, which will be available for replay for 90 days. Zymergen specializes in using biology to create innovative bio-based products across various industries through a unique integration of biology, chemistry, software, and automation.
Positive
- Anticipated financial results release for Q1 provides investors insight into company performance.
- Management's conference call will discuss business developments and future outlook.
Negative
- None.
Details
News Market Reaction – ZY
The recorded move for ZY in the trading session of this news was +12.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
A webcast of the conference call can be accessed at https://investors.zymergen.com/. The webcast will be archived and available for replay for at least 90 days after the event.
About Zymergen
Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Investor Contact
Niraj Javeri
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.